Tony J Kenna Selected Research

Tony J Kenna Research Topics

Disease

12	Ankylosing Spondylitis 01/2020 - 07/2011
5	Inflammation (Inflammations) 01/2018 - 12/2012
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 10/2016
3	Neoplasms (Cancer) 01/2022 - 06/2010
3	Arthritis (Polyarthritis) 01/2020 - 01/2013
2	Disease Progression 01/2017 - 01/2016
2	Spondylitis 01/2017 - 01/2016
2	Joint Diseases (Joint Disease) 06/2014 - 01/2013
1	Systemic Scleroderma (Systemic Sclerosis) 02/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2024
1	Uveitis 01/2023
1	Reactive Arthritis (Reiter Disease) 01/2020
1	Spondylarthropathies 01/2020
1	Birdshot Chorioretinopathy 05/2019
1	Immune System Diseases (Immune Disorders) 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2016
1	Weill-Marchesani Syndrome 01/2016
1	Necrosis 11/2015
1	Disease Susceptibility (Diathesis) 07/2011
1	Anauxetic dysplasia 03/2011
1	Autoimmune Diseases (Autoimmune Disease) 01/2010

Drug/Important Bio-Agent (IBA)

7	AminopeptidasesIBA 01/2023 - 07/2011
3	HLA-B Antigens (HLA-B)IBA 01/2020 - 07/2013
2	AntigensIBA 01/2020 - 06/2010
2	EnzymesIBA 05/2019 - 01/2013
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2018 - 07/2011
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
2	CytokinesIBA 01/2017 - 01/2013
2	Proteoglycans (Proteoglycan)IBA 01/2017 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 11/2015 - 01/2013
2	Peptides (Polypeptides)IBA 07/2013 - 07/2011
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	Histocompatibility Antigens Class IIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	LigandsIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	Fibrillin-1IBA 01/2016
1	Endoplasmic Reticulum Chaperone BiPIBA 11/2015
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 06/2014
1	Interleukin-1 (Interleukin 1)IBA 01/2013
1	Interleukin-17 (Interleukin 17)IBA 01/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	Toll-Like Receptor 7IBA 12/2012
1	Imiquimod (Aldara)FDA LinkGeneric 12/2012
1	Interleukin-2 (IL2)IBA 12/2012
1	Interleukin-23 (Interleukin 23)IBA 05/2012
1	RNA (Ribonucleic Acid)IBA 03/2011
1	mitochondrial RNA-processing endoribonuclease (RNAse MRP)IBA 03/2011
1	Ribonucleases (Ribonuclease)IBA 03/2011
1	Mitochondrial RNAIBA 03/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2010
1	Viral AntigensIBA 06/2010

Therapy/Procedure

4	Immunotherapy 01/2022 - 01/2010
4	Therapeutics 01/2018 - 12/2012